illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Sihuan Pharmaceuticals
Company logo

Sihuan Pharmaceuticals | Sustainability Performance

http://www.sihuanpharm.com.cn/

Focuses on drug research, development, and pharmaceutical production.

2001

China

11 - 50 employees

Pharmaceuticals

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#8807
Overallⓘ
#498
in Chinaⓘ
#214
in Pharmaceuticalsⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

257 out of 287

Overview

View similiar companies


Company logo
China National Accord Medicines

China, Health Care, Pharmaceuticals


Company logo
Shandong Buchang Pharmaceuticals

China, Health Care, Pharmaceuticals


Company logo
Shanghai Fudan Zhangjiang Bio Pharmaceutical

China, Health Care, Pharmaceuticals

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

    Available in
    Scale package

    Access
  • Email

  • Email